^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    NEO_PLIN2101

    i
    Associations
    News

    Trials

    Company:
    NeoCura
    Drug class:
    Immunostimulant, T-cell stimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer, Esophageal Cancer and Liver Cancer (NCT05192460)
    Phase N/A
    jianming xu
    Recruiting
    Last update posted :
    03/07/2023
    Initiation :
    03/28/2022
    Primary completion :
    12/01/2024
    Completion :
    06/01/2025
    IL6 • CD4 • IL2 • IL10
    |
    NEO_PLIN2101